基本信息
views: 106
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Research InterestsChatterjee
Our principal research interests are in genetic and molecular endocrinology, with particular emphasis on disorders nuclear hormone synthesis and action. We study several human disorders: Resistance to Thyroid Hormone (RTH), defined broadly as abnormal circulating thyroid hormones with tissue refractoriness to hormone action; and PPARgamma gene defects associated with lipodystrophic insulin resistance. Candidate gene and whole exome approaches are used to identify novel genetic aetiologies mediating defective hormone action. Human phenotypic studies elucidate mechanisms whereby thyroid hormones alter physiological processes acting via receptor subtypes in tissues. In a multisystem selenoprotein deficiency disorder including thyroid deiodinase enzymes, we are investigating features (cardiovascular, metabolic, photosensitivity) attributable to elevated ROS and the roles of selenoproteins of unknown function. Finally, we translate our research into technologies (biochemical, genetic) that comprise our national diagnostic laboratory service, develop biomarkers of hormone action and trial therapies (e.g. selective thyromimetics) that are applicable to commoner thyroid dysfunction or metabolic disorders.
Our principal research interests are in genetic and molecular endocrinology, with particular emphasis on disorders nuclear hormone synthesis and action. We study several human disorders: Resistance to Thyroid Hormone (RTH), defined broadly as abnormal circulating thyroid hormones with tissue refractoriness to hormone action; and PPARgamma gene defects associated with lipodystrophic insulin resistance. Candidate gene and whole exome approaches are used to identify novel genetic aetiologies mediating defective hormone action. Human phenotypic studies elucidate mechanisms whereby thyroid hormones alter physiological processes acting via receptor subtypes in tissues. In a multisystem selenoprotein deficiency disorder including thyroid deiodinase enzymes, we are investigating features (cardiovascular, metabolic, photosensitivity) attributable to elevated ROS and the roles of selenoproteins of unknown function. Finally, we translate our research into technologies (biochemical, genetic) that comprise our national diagnostic laboratory service, develop biomarkers of hormone action and trial therapies (e.g. selective thyromimetics) that are applicable to commoner thyroid dysfunction or metabolic disorders.
Research Interests
Papers共 291 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Luca Persani,Patrice Rodien,Carla Moran, W Edward Visser,Stefan Groeneweg, Robin P Peeters,Samuel Refetoff,Mark Gurnell,Paolo Beck-Peccoz,Krishna Chatterjee
European thyroid journal (2024)
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMno. 4 (2024): 1094-1108
Luca Stefanucci,Camous Moslemi, Ana R Tomé, Samuel Virtue,Guillaume Bidault, Nicholas S Gleadall, Laura P E Watson, Jing E Kwa, Frances Burden, Samantha Farrow, DBDS Genetic Consortium, Ji Chen,
Med (New York, N.Y.) (2024)
Carla Moran,Faraneh Vargha‐Khadem,Chris Clark, Kiran K. Seunarine, F. Muntoni, Richard A. I. Bethlehem, Keith Lindley,Laura Watson,Greta Lyons, Mehul Dattani,Krishna Chatterjee
Endocrine Abstracts (2023)
Clinical endocrinologyno. 2 (2023): 206-216
Nature communicationsno. 1 (2023): 3312-11
NATURE COMMUNICATIONSno. 1 (2023)
Endocrine Abstracts (2023)
Laura Watson,Tim J Cole,Greta Lyons, Christopher Georgiou,Jieniean Worsley, Katherine Carr,Peter Murgatroyd,Carla Moran,Krishna Chatterjee,Michelle Venables
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn